Likewise, progression-free and overall survival of patients with inoperable lung cancer who received cisplatin-based chemotherapy was higher when tumors expressed high levels of UCP2 as compared to tumors with low UCP2 levels (Su et al., 2012). Here, UCP2 is linked to lung carcinoma.